Drugs / Hib-MenCY-TT
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01978093 | Feb 2014 → Mar 2016 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib-MenCY-TT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01978093 ↗ |
| Known as | MenHibrix | “Biological: Hib-MenCY-TT (MenHibrix®)” NCT01978093 ↗ |
| Modality | Vaccine | “Hib-MenCY-TT (MenHibrix®) vaccine” NCT01978093 ↗ |